hypo evs (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
93
Structured Review
MedChemExpress
hypo evs
Hypo Evs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-n4108/Hypophyllanthin/pm38197482-73-41-86
Average 93 stars, based on 1 article reviews
Hypo Evs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-n4108/Hypophyllanthin/pm38197482-73-41-86
Average 93 stars, based on 1 article reviews
hypo evs - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Lysis:Article Title: SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma. Article Snippet: .. Tissue samples were firstly homogenized by tissue grinders in lysis buffer containing 150mM NaCl, 25mM TrisCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, protease inhibitor (Roche) and Protease Inhibitor:Article Title: SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma. Article Snippet: .. Tissue samples were firstly homogenized by tissue grinders in lysis buffer containing 150mM NaCl, 25mM TrisCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, protease inhibitor (Roche) and SDS Page:Article Title: SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma. Article Snippet: .. Tissue samples were firstly homogenized by tissue grinders in lysis buffer containing 150mM NaCl, 25mM TrisCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, protease inhibitor (Roche) and Incubation:Article Title: Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer. Article Snippet: Funding information General guidance project of Hunan Provincial Health Commission, Grant/Award Number: D202304086607 Abstract Gemcitabine (GEM) resistance affects chemotherapy efficacy of pancreatic cancer (PC).. Cancer‐associated fibroblasts (CAFs) possess the ability of regulating chemoresistance.. This study probed the mechanism of hypoxia‐treated CAFs regulating cell stemness and GEM resistance in PC. |